Detection of lung cancer relapse using self-reported symptoms transmitted via an Internet Web-application: pilot study of the sentinel follow-up
- 534 Downloads
We aimed to investigate whether patient self-evaluated symptoms transmitted via Internet can be used between planned visits to provide an early indication of disease relapse in lung cancer.
Between 2/2013 and 8/2013, 42 patients with lung cancer having access to Internet were prospectively recruited to weekly fill a form of 11 self-assessed symptoms called “sentinel follow-up”. Data were sent to the oncologist in real-time between planned visits. An alert email was sent to oncologist when self-scored symptoms matched some predefined criteria. Follow-up visit and imaging were then organized after a phone call for confirming suspect symptoms. Weekly and monthly compliances, easiness with which patients used the web-application and the accuracy of the sentinel follow-up for relapse detection were assessed and compared to a routine visit and imaging follow-up.
Median follow-up duration was 18 weeks (8–32). Weekly and monthly average compliances were 79 and 94 %, respectively. Sixty percents of patients declared to be less anxious during the few days before planned visit and imaging with the sentinel follow-up than without. Sensitivity, specificity, positive, and negative predictive values provided by the sentinel (planned imaging) follow-up were 100 %(84 %), 89 %(96 %), 81 %(91 %), and 100 %(93 %), respectively and well correlated with relapse (pχ 2 < 0.001). On average, relapses were detectable 5 weeks earlier with sentinel than planned visit.
An individualized cancer follow-up that schedule visit and imaging according to the patient status based on weekly self-reported symptoms transmitted via Internet is feasible with high compliance. It may even provide earlier detection of lung cancer relapse and care.
KeywordsLung cancer Follow-up Supportive care Personalized medicine Early relapse detection M-health
Financial disclosures, conflicts of interest
There are no financial disclosures, conflicts of interest, for the authors, and no funding sources for the manuscript.
- 6.Vansteenkiste J, De Ruysscher D, Eberhardt WE et al (2013) ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann OncolGoogle Scholar
- 7.Denis F, Viger L, Charron A et al (2013) Detecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up. Support Care CancerGoogle Scholar
- 12.NCCN Guidelines™ Version 1. (2012) Non-Small Cell Lung CancerGoogle Scholar